Tokyo, Japan

Chikaya Moriya

This inventor holds 1 USPTO granted patent. Top assignee: Dna Vec Research Inc.. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chikaya Moriya. Retrieved from https://idiyas.com/inventor/chikaya-moriya

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chikaya Moriya - Innovator in Recombinant Virus Technology

Introduction

Chikaya Moriya is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of viral vectors for therapeutic applications. Her innovative work has the potential to impact the treatment of various diseases.

Latest Patents

Chikaya Moriya holds a patent for a recombinant Sendai virus vector that includes a gene encoding a chemokine. This vector enables the large-scale production of clinically useful chemokines. The technology is particularly valuable for treating diseases that can be addressed through chemokine therapy.

Career Highlights

Moriya's career is marked by her dedication to advancing viral vector technology. Her work at Dna Vec Research Inc. has positioned her as a key figure in the biotechnology sector. She has focused on creating innovative solutions that enhance the efficacy of therapeutic agents.

Collaborations

Chikaya has collaborated with notable colleagues in her field, including Yoshiyuki Nagai and Tatsuo Shioda. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Chikaya Moriya's contributions to recombinant virus technology exemplify her commitment to innovation in biotechnology. Her work not only advances scientific knowledge but also holds promise for improving patient outcomes in various medical conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…